Navigation Links
Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Date:3/1/2011

s proprietary endothelial cell-based platform to prevent solid tumor growth, cancer recurrence and metastatic disease.

About Pervasis Pervasis Therapeutics, Inc. is a clinical stage company that is developing groundbreaking endothelial cell-based therapies designed to regulate the body's natural healing and repair processes in various critical therapeutic areas. The company has initially focused on developing therapies to improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stent placements, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs. The company's lead program, Vascugel®, has demonstrated proof of concept and safety in two Phase 2 clinical trials. Pervasis is also applying its endothelial cell-based platform technology to develop an oncology therapy focused on preventing solid tumor growth, cancer recurrence and metastatic disease, as well as products for inflammatory disease and orthopedic injury.

Pervasis is a privately held company with funding from Flagship Ventures, Polaris Venture Partners, Highland Capital Partners and the Richter Family Fund. For more information, please visit www.pervasistx.com.  

This news release contains certain forward-looking statements that involve risks and uncertainties. Such statements are only predictions and the company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may cause such differences include the timing of clinical trials, the risk that products that appeared promising in early research and clinical trials do not demonstrate safety or efficacy in clinical trials and the risk that the company will not obtain approval to market its products.

(1)  Dixon et al. DAC Study Group. Effect of dipyridamole plus aspirin on he
'/>"/>

SOURCE Pervasis Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
2. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
3. Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence
4. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
5. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
6. Mylan Receives Approval for Generic Version of Neurontin® Capsules
7. Elektas Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification
8. ViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software
9. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
10. Delcath Systems Receives Refusal to File Letter From FDA
11. Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Columbia Laboratories, Inc. ... a provider of pharmaceutical development, clinical trial manufacturing, and ... today announced that it will participate at the upcoming ... Conference, to be held in New York ... at 11:15am on September 9, 2014 at the New ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... May 19 Delcath Systems, Inc. (Nasdaq: ... device company focused on oncology, reconfirmed today that the ... oral presentation of Delcath,s Phase III Trial Data comparing ... care for patients with hepatic metastases from ocular or cutaneous ...
... Gift cards have dramatically evolved over the last decade, ... last-minute gift for hard-to-shop-for friends and family, gift cards are now a ... National Retail Federation , consumers spent $25 billion on ... , , ...
Cached Medicine Technology:Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 2Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 3Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 2Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 3Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 4Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 5Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 6Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts 7
(Date:8/27/2014)... Taking its popular obstacle race to a new ... will host its largest crowd at its 3rd Annual ... YMCA Camp Thunderbird . , Hundreds of ... and teams. Within each division, runners will attempt to conquer ... for a worthy cause. All proceeds will fund scholarships ...
(Date:8/27/2014)... All Canada Goose Parkas from CanadaGooseJackor.nu are great. ... modern. With unique detailing such as buttons, leather trim and ... up in opulence. Recently, the company has unveiled its new ... , True enough, the new assortment comes in various ... 28% off) on all these brand new items. By launching ...
(Date:8/27/2014)... The New York Mobility Club (sponsored by ... “ Sexuality & Intimacy ” for people with disabilities, ... discussions are for mature audiences only. September 9 from ... NY) and October 7 from 6-8 pm at Bussani ... New York Mobility Club is a local community group ...
(Date:8/27/2014)... 28, 2014 Recently, iFitDress.com, a professional ... its new designs of romantic bridal gowns . ... a promotional price (up to 66 percent off) when ... company’s product line has been updated with these new ... patient. iFitDress.com hopes that all clients can gain an ...
(Date:8/27/2014)... The Latinos In Action Festival 2014 is being ... Florida State Fair Grounds from 9am - 9pm. Latinos ... from around the world. Latinos in Action Festival is ... and Univision Mobile, a service provided by T-Mobile company. ... 4,000 people from different backgrounds, cultures and nationalities. Come ...
Breaking Medicine News(10 mins):Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2
... 9th September 2010. Due to increasing life-spans and improved ... measures indicate. In a new study, to ... International Institute for Applied Systems Analysis (IIASA) in Austria, ... of Demography (VID) have developed new measures of aging ...
... Airways Captain Chesley B. "Sully" Sullenberger III will be ... the Human Factors and Ergonomics Society,s 54th Annual Meeting ... on the Hudson River on January 15, 2009, will ... difference when confronting a challenge. "Preparing for Excellence: Leading ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Sept. 9 ... goals for the amount of fruit and vegetables people should ... not even close to reaching those thresholds, health officials said ... Disease Control and Prevention, in 2009, 67.5 percent of adults ...
... Reporter , THURSDAY, Sept. 9 (HealthDay News) -- A new ... if a child,s brain is maturing properly, potentially providing an ... say the strategy could turn an ordinary brain scan into ... pediatricians if kids are growing at an appropriate rate. ...
... This release is available in French . ... published in The Journal of Sexual Medicine has ... sympathy to women,s chronic vulvovaginal pain may trigger more pain, ... Women who took part in the study, conducted by the ...
... the world,s population is infected with Mycobacterium tuberculosis (MTB), ... death world-wide. A new discovery, led by a team ... Medicine, offers hope for new approaches to the prevention ... novel mechanism that may contribute to immune recognition of ...
Cached Medicine News:Health News:Study finds the effects of population aging have been exaggerated 2Health News:'Sully' Sullenberger keynotes HFES 54th Annual Meeting 2Health News:'Sully' Sullenberger keynotes HFES 54th Annual Meeting 3Health News:Most Americans Still Not Eating Enough Fruits, Veggies 2Health News:Most Americans Still Not Eating Enough Fruits, Veggies 3Health News:Brain Scans Could Spot Developmental Problems in Kids 2Health News:Romantic partner may play role in reducing vulvovaginal pain 2Health News:New dual recognition mechanism discovered in tuberculosis 2Health News:New dual recognition mechanism discovered in tuberculosis 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: